215 related articles for article (PubMed ID: 12683743)
1. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users.
Margolin A; Avants SK; Warburton LA; Hawkins KA; Shi J
Health Psychol; 2003 Mar; 22(2):223-8. PubMed ID: 12683743
[TBL] [Abstract][Full Text] [Related]
2. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.
Avants SK; Margolin A; Usubiaga MH; Doebrick C
J Subst Abuse Treat; 2004 Mar; 26(2):67-78. PubMed ID: 15050083
[TBL] [Abstract][Full Text] [Related]
3. Preparations for AIDS vaccine trials. Incident human immunodeficiency virus (HIV) infections in a cohort of injection drug users in Baltimore, Maryland.
Nelson KE; Vlahov D; Galai N; Astemborski J; Solomon L
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S201-5. PubMed ID: 7865301
[TBL] [Abstract][Full Text] [Related]
4. Drug use and HIV/AIDS in China.
Liu Z; Lian Z; Zhao C
Drug Alcohol Rev; 2006 Mar; 25(2):173-5. PubMed ID: 16627308
[TBL] [Abstract][Full Text] [Related]
5. Providers' HIV prevention discussions with HIV-seropositive injection drug users.
Wilkinson JD; Zhao W; Santibanez S; Arnsten J; Knowlton A; Gómez CA; Metsch LR;
AIDS Behav; 2006 Nov; 10(6):699-705. PubMed ID: 16639542
[TBL] [Abstract][Full Text] [Related]
6. HIV risk behaviors and HIV seropositivity among young injection drug users.
Marrero Rodríguez CA; Robles RR; Colón HM; Freeman DH; Matos TD; Reyes JC
P R Health Sci J; 1993 Apr; 12(1):7-12. PubMed ID: 8511250
[TBL] [Abstract][Full Text] [Related]
7. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
[TBL] [Abstract][Full Text] [Related]
8. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
Garfein RS; Swartzendruber A; Ouellet LJ; Kapadia F; Hudson SM; Thiede H; Strathdee SA; Williams IT; Bailey SL; Hagan H; Golub ET; Kerndt P; Hanson DL; Latka MH;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S4-17. PubMed ID: 17582705
[TBL] [Abstract][Full Text] [Related]
9. Relationship of HIV testing and high-risk behaviors among clients in methadone maintenance treatment.
Grella CE; Campos M; Anglin MD
AIDS Educ Prev; 1998 Oct; 10(5):403-16. PubMed ID: 9799937
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of a risk-reduction intervention with high-risk populations: the Harlem AIDS project.
Deren S; Davis WR; Beardsley M; Tortu S; Clatts M
AIDS Educ Prev; 1995 Oct; 7(5):379-90. PubMed ID: 8672391
[TBL] [Abstract][Full Text] [Related]
11. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.
Wood E; Li K; Miller CL; Hogg RS; Montaner JS; Schechter MT; Kerr T
Int J Epidemiol; 2005 Feb; 34(1):152-8. PubMed ID: 15561747
[TBL] [Abstract][Full Text] [Related]
12. Demographic characteristics, treatment history, drug risk behaviors, and condom use attitudes for U.S. and Russian injection drug users: the need for targeted sexual risk behavior interventions.
Ksobiech K; Somlai AM; Kelly JA; Gore-Felton C; Benotsch E; McAuliffe T; Hackl K; Ostrovski D; Kozlov AP
AIDS Behav; 2005 Mar; 9(1):111-20. PubMed ID: 15812618
[TBL] [Abstract][Full Text] [Related]
13. The dynamics of injection drug users' personal networks and HIV risk behaviors.
Costenbader EC; Astone NM; Latkin CA
Addiction; 2006 Jul; 101(7):1003-13. PubMed ID: 16771892
[TBL] [Abstract][Full Text] [Related]
14. Drug injection cessation among HIV-infected injecting drug users.
Bouhnik AD; Carrieri MP; Rey D; Spire B; Gastaut JA; Gallais H; Obadia Y;
Addict Behav; 2004 Aug; 29(6):1189-97. PubMed ID: 15236822
[TBL] [Abstract][Full Text] [Related]
15. Trends of HIV risk behaviors in a cohort of injecting drug users and their sex partners in Miami, Florida, 1988-1998.
McCoy CB; Metsch LR; Comerford M; Zhao W; Coltes AJ; Messiah SE
AIDS Behav; 2005 Jun; 9(2):187-99. PubMed ID: 15933838
[TBL] [Abstract][Full Text] [Related]
16. HIV infection among drug abusers in the Belgrade area.
Kilibarda M
Bull Narc; 1993; 45(1):135-46. PubMed ID: 8305903
[TBL] [Abstract][Full Text] [Related]
17. HIV diagnoses among injection-drug users in states with HIV surveillance--25 states, 1994-2000.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Jul; 52(27):634-6. PubMed ID: 12855944
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users.
Booth RE; Kwiatkowski CF; Stephens RC
J Psychoactive Drugs; 1998; 30(3):269-78. PubMed ID: 9798793
[TBL] [Abstract][Full Text] [Related]
20. Reduction in injection-related HIV risk after 6 months in a low-threshold methadone treatment program.
Millson P; Challacombe L; Villeneuve PJ; Strike CJ; Fischer B; Myers T; Shore R; Hopkins S
AIDS Educ Prev; 2007 Apr; 19(2):124-36. PubMed ID: 17411415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
